Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q4 2021 earnings call, dated Nov. 22, 2021. Corporate Participants: Vince Anzalone -- Vice President of Investor Relations Christopher
Arrowhead Pharmaceuticals Inc.
-(ARWR)
XNAS:ARWR
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Q1 2020 Earnings Call Transcript
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Q1 2020 Earnings Conference Call February 05, 2020 Corporate participants: Vincent Anzalone -- Vice President of Investor Relations
Arrowhead Pharmaceuticals (ARWR): FY 2019 Earnings Snapshot
-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported earnings of 69 cents per share during fiscal year 2019, compared to a loss of
Arrowhead Pharmaceuticals reports a loss of 12 cents per share in Q4
Arrowhead Pharmaceuticals (ARWR) reported Q4 and fiscal 2018 earnings results after the bell today. For the fourth quarter ended September 30, 2018, the